USPTO serial 85983821
Reviewed by CopyMark Law Group
Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active. Evaluate filing a new application if you still use the mark, or petition if cancellation was erroneous. Consult counsel on remaining common-law rights.
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Bad Homburg, DE
Bad Homburg, DE
Bad Homburg, DE
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Lee J. Eulgen
Lee J. Eulgen NEAL GERBER & EISENBERG LLP225 WEST RANDOLPH STREETSUITE 2800CHICAGO, IL 60606| Class | Description | Status | First use |
|---|---|---|---|
| 010 | blood washing machines, [ surgical clips; ] medical bags [ for medical fluids for use in dialysis; ] pumps and machines for enteral and parenteral feeding and structural and replacement parts thereof for medical use; needles for medical use; canulae; [ tubing for use in dialysis; ] Surgical and medical instruments and apparatus, namely, enteral feeding tubes, enteral feeding pumps, enteral giving sets for administration of enteral feeding; Programmable infusion medical device, namely, a medical infusion sets for global and interactive management of mono- and multi-channel infusion; infusion medical device, namely, medical machine for capturing and processing infusion data; Patient monitors, namely, a multi-channel patient monitor for critical care for analyzing, programming and monitoring patient information; Patient monitoring sensors and alarms; medical appliances and instruments, namely, syringe pumps and volumetric pumps; Medical apparatus, namely, patient monitoring communication racks for infusion; Surgical and medical apparatus and instruments, namely, infusion sets; Medical apparatus, namely, infusion and injection devices for administering drugs; Medical instruments to measure medicine dosage, hydration, nutrition, blood volume, and other physiological and cardiovascular parameters; Medical diagnostic apparatus, analytical apparatus for medical purposes and blood volume measuring apparatus; Medical accessories used in infusion technology, namely, clamps, connectors, syringes, joints for syringes, adapters, bags, cannulas, catheters, needles; Surgical and medical apparatus and instruments, namely, connectors for infusion sets and cannulas and tubes for infusion systems; medical device cannulae for continuous drug application subcutaneous; surgical and medical instruments and apparatus, particularly in connection with the implantation of port systems, namely, introducer instruments; infusion pumps and feeding tubes to administer parenteral drugs and parenteral nutrition solutions including accessories thereto, namely, clamps, connectors, syringes, joints for syringes, adapters, bags, cannulas, catheters and needles; Equipment and disposables used in pharmaceutical compounding of parenteral nutrition and intravenous drugs, namely, medical packaging combinations comprising medical bags and bottles sold empty and parts therefor; surgical and medical apparatus and instruments, namely, blood collection, mixing and weighing machine; surgical and medical apparatus and instruments, namely, blood donation and apheresis couches; surgical and medical apparatus and instruments, namely, docking port for sterile PVC connections and their disposables; surgical and medical instruments and apparatus, namely, seals for medical tubes; surgical and medical instruments and apparatus, namely, tube sealing system comprised of portable medical sealers and a high capacity battery; blood processing equipment for medical use, namely, whole blood cooling, transport and storage containers; haemoglobin screening devices for measuring haemoglobin out of human whole blood and its disposables, namely, cuvettes for single use; blood processing equipment for medical use, namely, automatic blood processing device for platelet concentrates agitation; blood processing disposables, namely, blood bags, pouches, sealers, caps, and containers for collection and processing of umbilical cord blood; blood processing disposables for medical use, namely, transfer bags, pouches, sealers, caps and containers for processing and administration of blood components; blood processing disposables for medical use, namely, whole blood and Red cell concentrate in-line filtration for flexible and individual processing; blood processing disposables for medical use, namely, conventional medical filters for leukodepletion and reduction of microaggregates from blood components; surgical and medical instruments and apparatus, namely, blood cell separator; apheresis device, namely, separation chamber; surgical and medical apparatus and instruments, namely, autotransfusion device; disposables used in autotransfusion, namely, separation chamber; Medical device, namely, continuous autotransfusion systems comprised of pumps, centrifuges, washing chambers, blood transfusion bags and tubing for surgical hemotherapy and intensive care and related data management software sold as a unit; parts for all of the aforesaid goods | SECTION 8 - CANCELLED | Nov 10, 2014 |
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
| Date | Code | Event | What it means |
|---|---|---|---|
| May 1, 2026 | CAEX | CANCELLED SEC. 8 (10-YR)/EXPIRED SECTION 9 | — |
| Jul 11, 2025 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Jul 11, 2025 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jul 11, 2025 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Oct 20, 2024 | REM2 | COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED | — |
| Jan 20, 2022 | NA85 | NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED | — |
| Jan 20, 2022 | C15A | REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK. | — |
| Jan 20, 2022 | APRE | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | — |
| Oct 8, 2021 | E815 | TEAS SECTION 8 & 15 RECEIVED | — |
| Oct 20, 2020 | REM1 | COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED | — |
| Oct 20, 2015 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Sep 15, 2015 | SUNA | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED | — |
| Sep 14, 2015 | CNPR | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED | — |
| Sep 14, 2015 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Sep 14, 2015 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Sep 5, 2015 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Sep 4, 2015 | SUPC | STATEMENT OF USE PROCESSING COMPLETE | — |
| Sep 4, 2015 | DPCC | DIVISIONAL PROCESSING COMPLETE | — |
| Sep 4, 2015 | EX4G | SOU EXTENSION 4 GRANTED | — |
| Aug 14, 2015 | DRRR | DIVISIONAL REQUEST RECEIVED | — |
| Aug 13, 2015 | IUAF | USE AMENDMENT FILED | — |
| Aug 13, 2015 | EXT4 | SOU EXTENSION 4 FILED | — |
| Aug 13, 2015 | ERTD | TEAS REQUEST TO DIVIDE RECEIVED | — |
| Aug 13, 2015 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Aug 13, 2015 | EISU | TEAS STATEMENT OF USE RECEIVED | The applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action. |
| Feb 20, 2015 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Feb 19, 2015 | DPCC | DIVISIONAL PROCESSING COMPLETE | — |
| Feb 19, 2015 | EX3G | SOU EXTENSION 3 GRANTED | — |
| Feb 4, 2015 | INOA | AMENDMENT AFTER NOA NOT ENTERED | — |
| Feb 4, 2015 | DRRR | DIVISIONAL REQUEST RECEIVED | — |
| Feb 4, 2015 | EXT3 | SOU EXTENSION 3 FILED | — |
| Feb 4, 2015 | ERTD | TEAS REQUEST TO DIVIDE RECEIVED | — |
| Feb 4, 2015 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Aug 7, 2014 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Aug 6, 2014 | EX2G | SOU EXTENSION 2 GRANTED | — |
| Aug 6, 2014 | AITU | CASE ASSIGNED TO INTENT TO USE PARALEGAL | — |
| Jul 11, 2014 | EXT2 | SOU EXTENSION 2 FILED | — |
| Jul 11, 2014 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Jan 23, 2014 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Jan 21, 2014 | EX1G | SOU EXTENSION 1 GRANTED | — |
| Jan 21, 2014 | EXT1 | SOU EXTENSION 1 FILED | — |
| Jan 21, 2014 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Aug 13, 2013 | NOAM | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Jun 19, 2013 | NPUB | NOTICE OF PUBLICATION | — |
| Jun 18, 2013 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Jun 18, 2013 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| May 29, 2013 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| May 15, 2013 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| May 15, 2013 | ALIE | ASSIGNED TO LIE | — |
| May 6, 2013 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Apr 26, 2013 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Apr 26, 2013 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Apr 26, 2013 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Apr 26, 2013 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Apr 24, 2013 | DOCK | ASSIGNED TO EXAMINER | — |
| Feb 26, 2013 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Feb 22, 2013 | NWAP | NEW APPLICATION ENTERED | — |